CVKD · Cadrenal Therapeutics, Inc. · Investor Relations
$0.94
0.00 (-0.47%)
At close · Oct 29
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date the accompanying financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$3.38M
Shares
3.57M
Volume · Oct 29
44.03K
Avg daily vol (3M)
461.96K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-29 | Lytham Partners Fall 2026 Investor Conference | Conference |
| 2026-09-14 | 28th Annual H.C. Wainwright Global Investment Conference | Conference |
| 2026-05-28 | Lytham Partners Spring 2026 Investor Conference | Conference |
| 2026-01-15 | Lytham Partners 2026 Investor Healthcare Summit | Webcast |
| 2025-09-30 | Lytham Partners Fall 2025 Investor Conference | Conference |